dpp 4 glp 1 combination DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
The study also analyzed 17 studies involving over 100,000 participants and found that the use of GLP-1 agonists did not significantly affect the occurrence of pancreatitis and pancreatic cancer compared to using a placebo
In addition, side effects, repeated injections, as well as cost and access are all contributing barriers at the moment
After 21 days at room temperature, the pen must be discarded
No personalized formulations like adding B12 or other supportive ingredients
